The Pan-Mass Challenge (PMC), an athletic fundraiser in the US, has donated $72m to the Dana-Farber Cancer Institute.
The donation is being claimed to be PMC’s largest ever for cancer research and treatment.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
This brings PMC’s total support to Dana-Farber through the Jimmy Fund to $972m since its inception in 1980.
PMC aims to surpass the $1bn mark for the Institute by 2024, continuing its support for cancer research and treatment.
The five-year relative cancer survival rate was 50% in 1980 when PMC was launched. Currently, the rate has increased to over 65%.
Other achievements include funding for blood tests for early detection of rare paediatric kidney cancer and recurrent HPV-driven oropharyngeal cancer.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe $72m gift was revealed at a celebratory event in Boston.
PMC remains the primary contributor to Dana-Farber, contributing 62% of the Jimmy Fund’s annual revenue.
As a federally designated Comprehensive Cancer Center and an affiliate of Harvard Medical School, Dana-Farber delivers advanced cancer treatments for adults through the Dana-Farber Brigham Cancer Center and for children through the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.
It has carried out more than 1,100 clinical trials.
PMC founder and executive director Billy Starr said: “Our riders continue to expand the very definition of what a bike-a-thon, and a bicycle, was really meant to do! Their support of the PMC and Dana-Farber is unwavering.
“The impact this year’s gift has is unparalleled and, as we head towards $1bn cumulatively raised, this is a proud moment to celebrate the progress that has been made in the fight against cancer thanks in large part to PMC fundraising efforts.”
